Linical is a global Contract Research Organization (CRO) for full-service drug development, with a proven record of helping biopharmaceutical companies successfully navigate the clinical development journey. Linical is headquartered in Japan with a significant presence across all major markets including Europe, North America, and Asia-Pacific. Within Germany, Linical has a presence in Frankfurt and Munich. Linical provides a full spectrum of drug development services from early stage to large-scale, multinational studies. Combining strong business perspective with clinical and medical expertise, our team goes beyond operational excellence providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. We strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market.

At Linical, we believe in supporting our clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.